Furthermore, we found that the AML drug decitabine, hypomethylating DNA by inhibiting DNA methyltransferase, significantly reduced the expression of TIGAR while induced the expression of PFKFB3 in HL-60 cells (Additional file 2: Figure S2c). The gene discussed is TIGAR; the disease is acute myeloid leukemia.